Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NKVYN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DMUC-4064A
|
|||||
| Synonyms |
D-4064A; DMUC 4064A; DMUC 4064A, RG788 2; DMUC-4064A; DMUC4064A; RG 7882; RG-7882; RG7882
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.; Roche Holding AG
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
MMUC3333A
|
Antibody Info | ||||
| Antigen Name |
Mucin-16 (MUC16)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Reactive Cysteines
|
|||||
| Combination Type |
vedotin
|
|||||
| Puchem SID | ||||||
| ChEBI ID | ||||||
